CURIA FRANCE SAS
Overview
CURIA FRANCE SAS is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering AZTREONAM ALFA FORM; AZTREONAM BETA FORM.
Core services & business areas
API / Drug Master Files
CURIA FRANCE SAS holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- AZTREONAM ALFA FORMActive2024-05-21
- AZTREONAM BETA FORMActive2023-05-12
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CURIA FRANCE SAS in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this CURIA FRANCE SAS? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.